SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 30.83 |
| Enterprise Value ($M) | -42.94 |
| Book Value ($M) | 116.44 |
| Book Value / Share | 21.91 |
| Price / Book | 0.26 |
| NCAV ($M) | 108.95 |
| NCAV / Share | 20.50 |
| Price / NCAV | 0.28 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.43 |
| Return on Assets (ROA) | -0.42 |
| Return on Equity (ROE) | -0.89 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.56 |
| Current Ratio | 7.56 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 143.21 |
| Assets | 150.70 |
| Liabilities | 34.25 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 3.94 |
| Operating Income | -89.15 |
| Net Income | -131.21 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -80.74 |
| Cash from Investing | -18.28 |
| Cash from Financing | 0.35 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Woodline Partners LP | 5.20 | ||
| 13G | Alyeska Investment Group, L.P. | 9.99 | 261.84 | |
| 13G/A | EcoR1 Capital, LLC | 3.90 | -40.85 | |
| 13D/A | Blatt Lawrence | 3.20 | -95.49 | |
| 13G/A | Armistice Capital, Llc | 4.99 | -41.07 | |
| 13G/A | Adage Capital Management, L.P. | 9.38 | 48.53 | |
| 13G/A | Vivo Capital Fund VIII, L.P. | 4.00 | ||
| 13G/A | Hillhouse Capital Advisors, Ltd. | 4.00 | -97.91 | |
| 13G | Ics Opportunities Ii Llc | 4.10 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| General risk factors | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 35,488 | 131,623 | 26.96 | |
| 105,179 | 314,466 | 33.45 | |
| 89,098 | 356,521 | 24.99 | |
| 87,704 | 308,628 | 28.42 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AKAN – Akanda Corp. | AKBA – Akebia Therapeutics, Inc. |
| ALDX – Aldeyra Therapeutics, Inc. | ALZN – Alzamend Neuro, Inc. |
| ANEB – Anebulo Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io